Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Zander

Showing results (421-430 of 456) with videos related to

Pageof 46
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 20, 2012
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myelomaNicolaus Kröger, Anita Badbaran, Tatjana Zabelina, et al.
Bone Marrow Transplantation|June 21, 2006
Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functionsF A Giordano, B Fehse, A Hotz-Wagenblatt, et al.
Journal of the National Cancer Institute|June 30, 2012
Role of interleukin 16 in multiple myelomaDjordje Atanackovic, York Hildebrandt, Julia Templin, et al.
Annals of Hematology|July 20, 2000
ASHAP--an effective salvage therapy for recurrent and refractory malignant lymphomasM Hänel, N Kröger, M M Hoffknecht, et al.
Leukemia|February 23, 2011
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemiaC Craddock, M Labopin, S Pillai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remissionMichael G Kiehl, Ludwig Kraut, Rainer Schwerdtfeger, et al.
Haematologica|July 22, 2008
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantationFrancis Ayuk, José A Perez-Simon, Avichai Shimoni, et al.
Blood|October 7, 2006
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantationDjordje Atanackovic, Julia Arfsten, Yanran Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Bone Marrow Transplantation|October 24, 2000
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemiaN Kröger, T Zabelina, S Sonnenberg, et al.
Pageof 46

Showing results (421-430 of 456) with videos related to

Sort By:
Pageof 46
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 20, 2012
Impact of high-risk cytogenetics and achievement of molecular remission on long-term freedom from disease after autologous-allogeneic tandem transplantation in patients with multiple myelomaNicolaus Kröger, Anita Badbaran, Tatjana Zabelina, et al.
Bone Marrow Transplantation|June 21, 2006
Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functionsF A Giordano, B Fehse, A Hotz-Wagenblatt, et al.
Journal of the National Cancer Institute|June 30, 2012
Role of interleukin 16 in multiple myelomaDjordje Atanackovic, York Hildebrandt, Julia Templin, et al.
Annals of Hematology|July 20, 2000
ASHAP--an effective salvage therapy for recurrent and refractory malignant lymphomasM Hänel, N Kröger, M M Hoffknecht, et al.
Leukemia|February 23, 2011
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemiaC Craddock, M Labopin, S Pillai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remissionMichael G Kiehl, Ludwig Kraut, Rainer Schwerdtfeger, et al.
Haematologica|July 22, 2008
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantationFrancis Ayuk, José A Perez-Simon, Avichai Shimoni, et al.
Blood|October 7, 2006
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantationDjordje Atanackovic, Julia Arfsten, Yanran Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2012
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Bone Marrow Transplantation|October 24, 2000
Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemiaN Kröger, T Zabelina, S Sonnenberg, et al.
Pageof 46